Due to poor air quality, the Academy San Francisco offices will be closed Friday, Nov. 16. 

    AGS 2017
    Glaucoma, IOP and Aqueous Flow, Surgical Management

    Cyclophotocoagulation (CPC) is an effective form of cycloablative therapy, but it has been historically associated with numerous risks and considered a treatment of last resort. In this interview from AGS 2017, Dr. Jonathan Myers discusses the Micropulse (Iridex), a new transscleral diode laser CPC platform that appears to have a better safety profile than its predecessor. At the meeting, the 10 posters on the Micropulse showed good pressure reduction and success rates ranging from 50% to 80%. The incidence of reported side effects was low, with cystoid macular edema and loss of ≥2 lines of BCVA the most common.